Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mapstone

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Pathways linking pulse pressure to dementia in adults with Down syndromeBatool Rizvi, Patrick J Lao, Mithra Sathishkumar, et al.
The Journal of Prevention of Alzheimer'S Disease|June 10, 2025
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adultsAlison R Bamford, Jenna N Adams, Soyun Kim, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2022
Joint-label fusion brain atlases for dementia research in Down syndromeNazek Queder, Michael J Phelan, Lisa Taylor, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Brain Communications|May 20, 2024
A pathway linking pulse pressure to dementia in adults with Down syndromeBatool Rizvi, Patrick J Lao, Mithra Sathishkumar, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively StableJr-Jiun Liou, Jerry Lou, Jamie Nakagiri, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Pathways linking pulse pressure to dementia in adults with Down syndromeBatool Rizvi, Patrick J Lao, Mithra Sathishkumar, et al.
The Journal of Prevention of Alzheimer'S Disease|June 10, 2025
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adultsAlison R Bamford, Jenna N Adams, Soyun Kim, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2022
Joint-label fusion brain atlases for dementia research in Down syndromeNazek Queder, Michael J Phelan, Lisa Taylor, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Brain Communications|May 20, 2024
A pathway linking pulse pressure to dementia in adults with Down syndromeBatool Rizvi, Patrick J Lao, Mithra Sathishkumar, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively StableJr-Jiun Liou, Jerry Lou, Jamie Nakagiri, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Pageof 15